145 related articles for article (PubMed ID: 38794899)
21. The impacts of probiotics in eradication therapy of Helicobacter pylori.
Bai X; Zhu M; He Y; Wang T; Tian D; Shu J
Arch Microbiol; 2022 Nov; 204(12):692. PubMed ID: 36344628
[TBL] [Abstract][Full Text] [Related]
22. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.
Liou JM; Chen CC; Chang CM; Fang YJ; Bair MJ; Chen PY; Chang CY; Hsu YC; Chen MJ; Chen CC; Lee JY; Yang TH; Luo JC; Chen CY; Hsu WF; Chen YN; Wu JY; Lin JT; Lu TP; Chuang EY; El-Omar EM; Wu MS;
Lancet Infect Dis; 2019 Oct; 19(10):1109-1120. PubMed ID: 31559966
[TBL] [Abstract][Full Text] [Related]
23. In Silico Profiling of the Potentiality of Curcumin and Conventional Drugs for CagA Oncoprotein Inactivation.
Srivastava AK; Tewari M; Shukla HS; Roy BK
Arch Pharm (Weinheim); 2015 Aug; 348(8):548-55. PubMed ID: 25996140
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing.
Park CH; Lee AR; Lee YR; Eun CS; Lee SK; Han DS
Helicobacter; 2019 Feb; 24(1):e12547. PubMed ID: 30440093
[TBL] [Abstract][Full Text] [Related]
25. Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
[TBL] [Abstract][Full Text] [Related]
26. Gut Microbiota: The Missing Link Between
Martin-Nuñez GM; Cornejo-Pareja I; Clemente-Postigo M; Tinahones FJ
Front Endocrinol (Lausanne); 2021; 12():639856. PubMed ID: 34220702
[No Abstract] [Full Text] [Related]
27. Helicobacter pylori and oral-gut microbiome: clinical implications.
Elghannam MT; Hassanien MH; Ameen YA; Turky EA; ELattar GM; ELRay AA; ELTalkawy MD
Infection; 2024 Apr; 52(2):289-300. PubMed ID: 37917397
[TBL] [Abstract][Full Text] [Related]
28. Effect of
Guo Y; Cao XS; Guo GY; Zhou MG; Yu B
Front Cell Infect Microbiol; 2022; 12():899248. PubMed ID: 35601105
[TBL] [Abstract][Full Text] [Related]
29. Research trends on the relationship between Helicobacter pylori and microbiota: A bibliometric analysis.
Li Y; Ouyang Y; He C
Helicobacter; 2023 Dec; 28(6):e13021. PubMed ID: 37697432
[TBL] [Abstract][Full Text] [Related]
30. Comparison of concomitant therapy versus standard triple-drug therapy for eradication of Helicobacter pylori infection: A prospective open-label randomized controlled trial.
Jha SK; Mishra MK; Saharawat K; Jha P; Purkayastha S; Ranjan R
Indian J Gastroenterol; 2019 Aug; 38(4):325-331. PubMed ID: 31520370
[TBL] [Abstract][Full Text] [Related]
31. H. pylori eradication with antibiotic treatment causes changes in glucose homeostasis related to modifications in the gut microbiota.
Martín-Núñez GM; Cornejo-Pareja I; Coin-Aragüez L; Roca-Rodríguez MDM; Muñoz-Garach A; Clemente-Postigo M; Cardona F; Moreno-Indias I; Tinahones FJ
PLoS One; 2019; 14(3):e0213548. PubMed ID: 30870471
[TBL] [Abstract][Full Text] [Related]
32. Natural products and food components with anti-Helicobacter pylori activities.
Takeuchi H; Trang VT; Morimoto N; Nishida Y; Matsumura Y; Sugiura T
World J Gastroenterol; 2014 Jul; 20(27):8971-8. PubMed ID: 25083070
[TBL] [Abstract][Full Text] [Related]
33. Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of
Yang SJ; Huang CH; Yang JC; Wang CH; Shieh MJ
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54316-54327. PubMed ID: 33236884
[No Abstract] [Full Text] [Related]
34. Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori.
Zaidi SF; Yamada K; Kadowaki M; Usmanghani K; Sugiyama T
J Ethnopharmacol; 2009 Jan; 121(2):286-91. PubMed ID: 19041711
[TBL] [Abstract][Full Text] [Related]
35. Effects of
Engelsberger V; Gerhard M; Mejías-Luque R
Front Cell Infect Microbiol; 2024; 14():1339750. PubMed ID: 38343887
[TBL] [Abstract][Full Text] [Related]
36. The Effect of Helicobacter pylori Eradication on the Gastrointestinal Microbiota in Patients with Duodenal Ulcer.
Li L; Zhou X; Xiao S; Ye F; Zhang G
J Gastrointestin Liver Dis; 2016 Jun; 25(2):139-46. PubMed ID: 27308643
[TBL] [Abstract][Full Text] [Related]
37. Changes in the human gut microbiota composition caused by Helicobacter pylori eradication therapy: A systematic review and meta-analysis.
Ye Q; Shao X; Shen R; Chen D; Shen J
Helicobacter; 2020 Aug; 25(4):e12713. PubMed ID: 32515529
[TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori eradication with a 7-day low-dose triple therapy in hemodialysis patients.
Chang WC; Jo YI; Park HS; Jegal J; Park JH; Lee JH; Jin CJ
Clin Exp Nephrol; 2010 Oct; 14(5):469-73. PubMed ID: 20632062
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori treatment: antibiotics or probiotics.
Goderska K; Agudo Pena S; Alarcon T
Appl Microbiol Biotechnol; 2018 Jan; 102(1):1-7. PubMed ID: 29075827
[TBL] [Abstract][Full Text] [Related]
40. The relationship of gastric microbiota and Helicobacter pylori infection in pediatrics population.
Miao R; Wan C; Wang Z
Helicobacter; 2020 Feb; 25(1):e12676. PubMed ID: 31762120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
